2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
- CAS No.
- 1579965-12-0
- Chemical Name:
- 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
- Synonyms
- GSK2983559 free acid;GSK2983559 (compound 3);2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate;Ethanol,2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-,dihydrogenphosphate(ester);Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-, 1-(dihydrogen phosphate);inhibit,THP-1 cell,RIP kinase,GSK 2983559,GSK2983559 free acid,Inhibitor,GSK-2983559,RIPK,Receptor-interacting protein kinases,GSK-2983559 free acid,GSK2983559
- CBNumber:
- CB93054278
- Molecular Formula:
- C21H23N4O7PS2
- Molecular Weight:
- 538.53
- MDL Number:
- MFCD30489430
- MOL File:
- 1579965-12-0.mol
- MSDS File:
- SDS
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate Properties
Boiling point | 823.6±75.0 °C(Predicted) |
---|---|
Density | 1.537±0.06 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | DMF: slightly soluble; DMSO: 1 mg/ml; PBS (pH 7.2): 1 mg/ml |
form | A crystalline solid |
pka | 1.76±0.10(Predicted) |
color | Light yellow to yellow |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate price
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate Chemical Properties,Uses,Production
Uses
GSK2983559 free acid (compound 3) is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 free acid can block many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples[1].
in vivo
GSK2983559 (oral gavage; 3 and 10 mg/kg; once) inhibits effectively MDP-induced IL-6 in mouse[2].
Animal Model: | C57BL/6 mice (female) injected with MDP (100 μg)[2] |
Dosage: | 3 and 10 mg/kg |
Administration: | Oral gavage; 3 and 10 mg/kg; once |
Result: | Suppressed serum IL-6 levels in a dose-dependent manner. |
IC 50
RIPK2
References
[1] Haile PA, et al. Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases. J Med Chem. 2019 Jul 25;62(14):6482-6494. DOI:10.1021/acs.jmedchem.9b00575
[2] Shuwei Wu, et al. Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors. Bioorg Med Chem Lett. 2022 Sep 2;75:128968. DOI:10.1016/j.bmcl.2022.128968
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32274 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | laboratory@coreychem.com | China | 30230 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10473 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3135 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38664 | 58 | |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | masar@topule.com | China | 8467 | 58 |
Aladdin Scientific | tp@aladdinsci.com | United States | 57505 | 58 |
View Lastest Price from 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2024-11-19 | GSK2983559 free acid
1579965-12-0
|
US $35.00-122.00 / mg | 98.61% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2024-11-19 | GSK2983559 free acid
1579965-12-0
|
US $35.00-122.00 / mg | 98.61% | 10g | TargetMol Chemicals Inc. |
-
- GSK2983559 free acid
1579965-12-0
- US $35.00-122.00 / mg
- 98.61%
- TargetMol Chemicals Inc.
-
- GSK2983559 free acid
1579965-12-0
- US $35.00-122.00 / mg
- 98.61%
- TargetMol Chemicals Inc.
1579965-12-0(2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate)Related Search:
1of4